×
Does Pharmacogenomic Testing Improve Clinical Outcomes for Major Depressive Disorder? A Systematic Review of Clinical Trials and Cost-Effectiveness Studies PDF
$ 40.00
Does Pharmacogenomic Testing Improve Clinical Outcomes for Major Depressive Disorder? A Systematic Review of Clinical Trials and Cost-Effectiveness Studies PDF quantity
$ 40.00
×
Rehabilitation PDF
$ 40.00
Rehabilitation PDF quantity
$ 40.00
×
Prolactin Levels in Schizophrenia and Schizoaffective Disorder Patients Treated With Clozapine, Olanzapine, Risperidone, or Haloperidol PDF
$ 40.00
Prolactin Levels in Schizophrenia and Schizoaffective Disorder Patients Treated With Clozapine, Olanzapine, Risperidone, or Haloperidol PDF quantity
$ 40.00
×
Psychostimulant Use in Schizophrenia for Treatment of Negative Symptoms and Weight Loss PDF
$ 40.00
Psychostimulant Use in Schizophrenia for Treatment of Negative Symptoms and Weight Loss PDF quantity
$ 40.00
×
Cyclosporine-Olanzapine Drug-Drug Interaction PDF
$ 40.00
Cyclosporine-Olanzapine Drug-Drug Interaction PDF quantity
$ 40.00
×
A Meta-Review of Lifestyle Interventions for Cardiovascular Risk Factors in the General Medical Population: Lessons for Individuals With Serious Mental Illness PDF
$ 40.00
A Meta-Review of Lifestyle Interventions for Cardiovascular Risk Factors in the General Medical Population: Lessons for Individuals With Serious Mental Illness PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart